James Coffin - 22 Jul 2021 Form 4 Insider Report for Sema4 Holdings Corp. (WGS)

Role
President and COO
Signature
/s/ Daniel Clark, Attorney-in-Fact
Issuer symbol
WGS
Transactions as of
22 Jul 2021
Net transactions value
$0
Form type
4
Filing time
26 Jul 2021, 18:53:51 UTC
Next filing
05 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGSWW Employee Stock Option (Right to Buy) Award +2,167,093 2,167,093 22 Jul 2021 Class A Common Stock 2,167,093 $0.1529 Direct F1, F2
transaction WGSWW Employee Stock Option (Right to Buy) Award +332,963 332,963 22 Jul 2021 Class A Common Stock 332,963 $0.7659 Direct F1, F2
transaction WGSWW Employee Stock Option (Right to Buy) Award +480,657 480,657 22 Jul 2021 Class A Common Stock 480,657 $0.7659 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 6.25% of the total shares underlying the option vest in quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
F2 Pursuant to the business combination between the Issuer (which was formerly known as CM Life Sciences, Inc.) and Mount Sinai Genomics, Inc. d/b/a Sema4 ("Sema4"), each share of Sema4 outstanding common stock was automatically converted into the right to shares of the Issuer's Class A Common Stock based on a 1 to 123.8338 exchange ratio ("Exchange Ratio"). In addition, each outstanding Sema4 equity award was automatically converted into a corresponding equity award of the Issuer based on the Exchange Ratio and with the same terms and vesting conditions as the Sema4 equity awards.

Remarks:

The merger agreement provides that certain former stockholders and equity award holders of Sema4 will receive additional shares of the Issuer's Class A common stock and awards of restricted stock units upon the achievement of certain vesting conditions.